Viatris

At Viatris, we believe in healthcare as it should be—empowering people worldwide to live healthier at every stage of life. Formed in November 2020 from the combination of Mylan and Upjohn, our mission is to provide high quality medications to patients, regardless of geography or circumstance. With a comprehensive product portfolio that includes brands, generics, and biosimilars, we strive to ensure that the medicines patients need are accessible to them.

Our name, Viatris, reflects our commitment to providing a path to achieving three critical goals: expanding access to medicines, leading through innovation to meet patient needs, and being a trusted partner to the healthcare community. We operate in more than 165 countries, leveraging our global scale and deep understanding of local markets to deliver quality healthcare solutions. As a partner of choice for businesses and patients, we connect our collective expertise to address emerging global health challenges while advancing sustainable operations to improve patient outcomes.